EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Gut microbiome compositional and functional features associate with Alzheimer's disease pathology

Jea Woo Kang iD, Lora A Khatib, Margo B Heston, Amanda H Dilmore, Jennifer S Labus, Yuetiva Deming, Leyla Schimmel, Colette Blach, Daniel McDonald, Antonio Gonzalez, MacKenzie Bryant, Tyler K Ulland und 11 weitere

Alzheimer's & Dementia · 2025-07 · 21 (7)

DOI: 10.1002/alz.70417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 02.07.2025. Verfasst von Jea Woo Kang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison…. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AD Strategic Fund and the Alzheimer's Association, NIA NIH HHS, European Union's Horizon Europe research and innovation programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The gut microbiome is a potentially modifiable risk factor for Alzheimer's disease (AD); however, understanding of its composition and function regarding AD pathology is limited. METHODS Shallow‐shotgun metagenomics was used to analyze the fecal microbiome of participants in the Wisconsin Microbiome in Alzheimer's Risk Study, leveraging clinical data and cerebrospinal fluid (CSF) biomarkers. Differential abundance and ordinary least squares regression analyses were performed to find differentially abundant gut microbiome features and their associations with CSF biomarkers of AD and related pathologies. RESULTS Gut microbiome composition and function differed between individuals with and without AD dementia. The compositional difference was replicated in an independent cohort. Differentially abundant gut microbiome features were associated with CSF biomarkers of AD and related pathologies. DISCUSSION These findings enhance our understanding of alterations in gut microbial composition and function in AD, and suggest that gut microbes and their pathways are linked to AD pathology. Highlights Gut microbiome composition and function differ between people with Alzheimer's disease (AD) dementia and cognitively unimpaired (CU) individuals. Co‐occurring gut microbes show differential abundance across AD‐related groups (AD vs CU, amyloid status+ vs amyloid status−, and apolipoprotein E ( APOE ) ε4 status+ vs APOE ε4 status−). Gut microbiome composition also differs between people with AD dementia and CU individuals in a larger validation cohort. Differentially abundant gut microbiome composition and function between AD and CU groups are correlated with cerebrospinal fluid biomarkers for AD and related pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGastrointestinal MicrobiomeHumansMaleFemaleAgedBiomarkersFecesMetagenomicsAmyloid beta-PeptidesAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerscerebrospinal fluidcompositiondifferential abundancefunctiongut microbiomepathology

Substanzen

BiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
  • Department of Pediatrics, University of California, San Diego, La Jolla, California, USA.
  • Neurosciences Graduate Program, University of California, San Diego, La Jolla, California, USA.
  • Integrative Biostatistics and Bioinformatics Core (IBBC) at the Goodman-Luskin Microbiome Center, Los Angeles, California, USA.
  • G. Oppenheimer Center for Neurobiology of Stress and Resilience, Los Angeles, California, USA.
  • UCLA Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

ORCID-Profile: Jea Woo Kang

Förderung

  • AD Strategic Fund and the Alzheimer's Association
  • NIA NIH HHS
  • European Union's Horizon Europe research and innovation programme
  • Swedish Research Council
  • Olav Thon Foundation
  • Bluefield Project
  • NIH HHS
  • European Partnership on Metrology co-financed from the European Union's Horizon Europe Research and Innovation Programme and by the Participating States

Zitieren

APA

Kang, J. W., Khatib, L. A., Heston, M. B., Dilmore, A. H., Labus, J. S., Deming, Y., Schimmel, L., Blach, C., McDonald, D., Gonzalez, A., Bryant, M., Ulland, T. K., Johnson, S. C., Asthana, S., Carlsson, C. M., Chin, N. A., Blennow, K., Zetterberg, H., Rey, F. E., …, & Bendlin, B. B. (2025). Gut microbiome compositional and functional features associate with Alzheimer's disease pathology. Alzheimer's & Dementia, 21(7). https://doi.org/10.1002/alz.70417

Vancouver

Kang JW, Khatib LA, Heston MB, Dilmore AH, Labus JS, Deming Y, et al. Gut microbiome compositional and functional features associate with Alzheimer's disease pathology. Alzheimer's & Dementia. 2025;21(7). doi:10.1002/alz.70417

BibTeX
@article{Kang2025,
  author = {Kang, Jea Woo and Khatib, Lora A and Heston, Margo B and Dilmore, Amanda H and Labus, Jennifer S and Deming, Yuetiva and Schimmel, Leyla and Blach, Colette and McDonald, Daniel and Gonzalez, Antonio and Bryant, MacKenzie and Ulland, Tyler K and Johnson, Sterling C and Asthana, Sanjay and Carlsson, Cynthia M and Chin, Nathaniel A and Blennow, Kaj and Zetterberg, Henrik and Rey, Federico E and Alzheimer Gut Microbiome Project Consortium, Alzheimer Gut Microbiome Project Consortium and Kaddurah-Daouk, Rima and Knight, Rob and Bendlin, Barbara B},
  title = {Gut microbiome compositional and functional features associate with Alzheimer's disease pathology},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {7},
  doi = {10.1002/alz.70417}
}
Kostenlos starten →